Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects An updated systematic review

被引:32
作者
Aminoshariae, Anita [1 ]
Kulild, James C. [2 ]
Donaldson, Mark [3 ,4 ,5 ]
机构
[1] Case Western Reserve Univ, Predoctoral Endodont, Sch Dent Med, 2124 Cornell Rd, Cleveland, OH 44106 USA
[2] Univ Missouri, Sch Dent, Dept Endodont, Kansas City, MO USA
[3] VHA Clin Pharm, Performance Serv, Irving, TX USA
[4] Univ Montana, Sch Pharm, Missoula, MT 59812 USA
[5] Oregon Hlth & Sci Univ, Sch Dent, Portland, OR 97201 USA
关键词
NSAIDs; cardiovascular risk; myocardial infarction; gastrointestinal; renal; respiratory; randomized controlled clinical trials; cohort studies; case-controlled studies; vascular events; LOW-DOSE ASPIRIN; RECEIVING ANTITHROMBOTIC THERAPY; EXACERBATED RESPIRATORY-DISEASE; SELECTIVE COX-2 INHIBITOR; RENAL-FUNCTION; MYOCARDIAL-INFARCTION; DOUBLE-BLIND; GASTROINTESTINAL TOLERABILITY; CYCLOOXYGENASE-2; INHIBITOR; ACETYLSALICYLIC-ACID;
D O I
10.1016/j.adaj.2015.07.020
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. In this article, the authors examine the available scientific evidence regarding adverse effects of short-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Short-term use was defined as 10 days or fewer. Methods. The authors reviewed randomized controlled clinical trials and cohort and case-controlled clinical studies published between 2001 and June 2015 in which the investigators reported on the safety of nonselective cyclooxygenase inhibitors and of cyclooxygenase-2 selective inhibitor NSAIDs. Results. The systematic review process according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines allowed the authors to identify 40 studies that met the inclusion criteria. Conclusions. On the basis of the available scientific evidence, NSAIDs may be considered relatively safe drugs when prescribed at the most effective dose and for the shortest duration of time, which was defined to be 10 days or fewer.
引用
收藏
页码:98 / 110
页数:13
相关论文
共 89 条
  • [1] Renal failure associated with the use of celecoxib and rofecoxib
    Ahmad, SR
    Kortepeter, C
    Brinker, A
    Chen, M
    Beitz, J
    [J]. DRUG SAFETY, 2002, 25 (07) : 537 - 544
  • [2] [Anonymous], ANALGESIA
  • [3] [Anonymous], LEX ONL DENT
  • [4] [Anonymous], MED GUID NONST ANT D
  • [5] [Anonymous], FDA STRENGTH WARN HE
  • [6] Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
    Antman, Elliott M.
    Bennett, Joel S.
    Daugherty, Alan
    Furberg, Curt
    Roberts, Harold
    Taubert, Kathryn A.
    [J]. CIRCULATION, 2007, 115 (12) : 1634 - 1642
  • [7] Gastrointestinal adverse effects of short-term aspirin use: A meta-analysis of published randomized controlled trials
    Baron J.A.
    Senn S.
    Voelker M.
    Lanas A.
    Laurora I.
    Thielemann W.
    Brückner A.
    McCarthy D.
    [J]. Drugs in R&D, 2013, 13 (1) : 9 - 16
  • [8] Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients:: Comparison of nimesulide, meloxicam, and rofecoxib
    Bavbek, S
    Çelik, G
    Özer, F
    Mungan, D
    Misirligil, Z
    [J]. JOURNAL OF ASTHMA, 2004, 41 (01) : 67 - 75
  • [9] Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps - A challenge-proven study
    Bavbek, Sevim
    Dursun, A. Berna
    Dursun, Engin
    Eryilmaz, Adil
    Misirligil, Zeynep
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2007, 142 (01) : 64 - 69
  • [10] Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson, F
    Reilly, MP
    Kapoor, SC
    Cucchiara, AJ
    DeMarco, S
    Tournier, B
    Vyas, SN
    FitzGerald, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (25) : 1809 - 1817